Please login to the form below

Not currently logged in
Email:
Password:

Foundation Medicine

This page shows the latest Foundation Medicine news and features for those working in and with pharma, biotech and healthcare.

Roche agrees $2.4bn takeover of genomics player Foundation

Roche agrees $2.4bn takeover of genomics player Foundation

Offers a 29% premium on the Foundation’s recent share price. Three years after taking a $1bn stake in Foundation Medicine, Roche has decided it wants to take complete control of ... The price is a 29% premium on Foundation’s June 18 share price and

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    AstraZeneca is collaborating with numerous firms in this field, including Foundation Medicine, which specialises in next-generation gene sequencing technology.

  • Real-world evidence Real-world evidence

    Mental Health Foundation; London School of Hygiene &Tropical Medicine; RWE consultant.

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Corporate acquisition. 5, 200. Foundation Medicine/Roche. Broad R&D collaboration to optimise oncology treatments via Foundations genomic analysis and molecular information.

  • Pharma deals during January 2015 Pharma deals during January 2015

    First up was the acquisition of a majority interest in Foundation Medicine for a total of $1.18bn.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Biogen Idec appoints senior neuroscientists Biogen Idec appoints senior neuroscientists

    Dr Henderson was most recently Gurewitsch and Vidda Foundation professor of Rehabilitation and Regenerative Medicine at Columbia University in New York City. ... He was also professor of Molecular Medicine at the Lerner College of Medicine at Case

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    However, in precision medicine, we ask what treatment is best for the patient? ... This sets out a clear need for treatment agnostic broad panel testing that provides physicians with a decision support mechanism.  Foundation Medicine  has risen to this

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics